이 페이지를 로드하는 동안 오류가 발생한 것 같습니다.
지원팀에 전달되었습니다. 만약 문제가 지속될 경우 이메일 지원 위젯을 통해 다시 문의 부탁드립니다.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| CareDx, Inc |
| iTeos Therapeutics, Inc. |
| PTC Therapeutics, Inc. |
| Coherus BioSciences, Inc. |
| Regen BioPharma, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| CDNA | ITOS | PTCT | CHRS | RGBP | RNTX | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 16% | -23% | 38% | -18% | 17% | NA | ||
| Fiscal Year - 1 | -55% | -18% | 108% | 144% | -16% | NA | ||
| Fiscal Year - 2 | -17% | 16% | 323% | NM | -21% | NA | ||
| Fiscal Year - 3 | -8% | 49% | -217% | -152% | 65% | NA | ||
| Fiscal Year - 4 | -10% | NA | -81% | 68% | -37% | NA | ||
| Fiscal Year - 5 | -23% | NA | -53% | 270% | 26% | NA | ||
| Average | -16% | 6% | 20% | 63% | 6% | NA | ||
| Median | -14% | -1% | -8% | 68% | 1% | NA | ||
| Benchmarks | Ticker | |||||||
| CareDx, Inc | NasdaqGM:CDNA | |||||||
| iTeos Therapeutics, Inc. | NasdaqGM:ITOS | |||||||
| PTC Therapeutics, Inc. | NasdaqGS:PTCT | |||||||
| Coherus BioSciences, Inc. | NasdaqGM:CHRS | |||||||
| Regen BioPharma, Inc. | OTCPK:RGBP | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | CDNA | ITOS | PTCT | CHRS | RGBP | RNTX | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Sep-24 | Dec-23 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Sep-24 | Sep-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 334 | 35 | 807 | 267 | 0 | NA | ||
| Fiscal Year | 334 | 35 | 807 | 267 | 0 | NA | ||
| Fiscal Year - 1 | 280 | 13 | 938 | 257 | 0 | NA | ||
| Fiscal Year - 2 | 322 | 268 | 699 | 211 | 0 | NA | ||
| Fiscal Year - 3 | 296 | 345 | 539 | 327 | 0 | NA | ||
| Fiscal Year - 4 | 192 | NA | 381 | 476 | 0 | NA | ||
| Fiscal Year - 5 | 127 | NA | 307 | 356 | 0 | NA | ||
| Net Income | ||||||||
| Latest Twelve Months | 53 | (134) | (363) | 29 | (1) | (29) | ||
| Fiscal Year | 53 | (134) | (363) | 29 | (1) | (16) | ||
| Fiscal Year - 1 | (190) | (113) | (627) | (238) | 1 | (27) | ||
| Fiscal Year - 2 | (77) | 97 | (559) | (292) | 2 | (26) | ||
| Fiscal Year - 3 | (31) | 215 | (524) | (287) | (7) | (21) | ||
| Fiscal Year - 4 | (19) | (43) | (438) | 132 | 3 | (29) | ||
| Fiscal Year - 5 | (22) | (27) | (252) | 90 | (3) | (32) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 467 | 668 | 1,896 | 630 | 0 | 13 | ||
| Latest Fiscal Quarter | 491 | 687 | 1,705 | 449 | 0 | 104 | ||
| Fiscal Year | 491 | 687 | 1,705 | 449 | 0 | 106 | ||
| Fiscal Year - 1 | 467 | 668 | 1,896 | 630 | 0 | 22 | ||
| Fiscal Year - 2 | 543 | 755 | 1,706 | 481 | 1 | 48 | ||
| Fiscal Year - 3 | 567 | 885 | 1,938 | 679 | 1 | 16 | ||
| Fiscal Year - 4 | 369 | 345 | 2,208 | 842 | 0 | 26 | ||
| Fiscal Year - 5 | 152 | 31 | 1,624 | 409 | 0 | 30 | ||
| Fiscal Year - 6 | 131 | 27 | 1,119 | 99 | 0 | 53 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 261 | 575 | (819) | (193) | (5) | 11 | ||
| Latest Fiscal Quarter | 378 | 590 | (1,098) | (132) | (5) | 50 | ||
| Fiscal Year | 378 | 590 | (1,098) | (132) | (5) | 7 | ||
| Fiscal Year - 1 | 261 | 575 | (819) | (193) | (5) | 19 | ||
| Fiscal Year - 2 | 431 | 663 | (347) | (137) | (8) | 44 | ||
| Fiscal Year - 3 | 466 | 553 | 1 | 98 | (14) | 12 | ||
| Fiscal Year - 4 | 278 | 323 | 482 | 281 | (7) | 16 | ||
| Fiscal Year - 5 | 99 | (36) | 594 | 105 | (11) | 20 | ||
| Fiscal Year - 6 | 96 | (11) | 351 | (39) | (9) | 48 | ||